Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | 57.3% | CN¥24.54B | -15.1x | -1.5 | CN¥50.40 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -23.4% Downside | Upgrade to Pro+ | |
Suzhou Zelgen Biopharma | Shanghai | Healthcare | Pharmaceuticals | 53.3% | CN¥24.40B | -198x | -4.02 | CN¥92.35 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.5% Upside | Upgrade to Pro+ | |
Sichuan Biokin Pharmaceutical | Shanghai | Healthcare | Pharmaceuticals | 48.2% | CN¥106.85B | 30.3x | 0.05 | CN¥271.93 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.2% Upside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | 36.2% | CN¥25.27B | -29.5x | -1.2 | CN¥56.34 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.8% Upside | Upgrade to Pro+ | |
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | 26.7% | CN¥175.68B | -60.7x | -1.25 | CN¥230.50 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.8% Upside | Upgrade to Pro+ | |
Beijing Abt Networks | Shanghai | Technology | Software & IT Services | 26.2% | CN¥4.44B | -37.5x | 0.06 | CN¥58.40 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | 21.7% | CN¥37.65B | 24.5x | 0.22 | CN¥84.31 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Niutech Environment Technology | Shanghai | Industrials | Professional & Commercial Services | 21% | CN¥1.31B | 57x | 0.48 | CN¥16.73 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chongqing Genrix Biopharmaceutical | Shanghai | Healthcare | Pharmaceuticals | 17.1% | CN¥9.75B | -13.3x | -1.74 | CN¥26.90 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangsu Leadmicro Nano Tech | Shanghai | Technology | Semiconductors & Semiconductor Equipment | 12.9% | CN¥13.25B | 43.9x | 4.76 | CN¥29.33 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | 12.4% | CN¥4.33B | -12.2x | -1.41 | CN¥7.83 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.4% Upside | Upgrade to Pro+ | |
Yuanjie Semiconductor Tech | Shanghai | Technology | Semiconductors & Semiconductor Equipment | 1.5% | CN¥11.67B | -5,039.3x | 45.28 | CN¥137 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.1% Downside | Upgrade to Pro+ | |
Ruida | Shenzhen | Financials | Investment Banking & Investment Services | 1.3% | CN¥7.35B | 18.8x | 0.34 | CN¥16.15 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.5% Downside | Upgrade to Pro+ | |
Huaxi Securities A | Shenzhen | Financials | Investment Banking & Investment Services | -1.8% | CN¥21.84B | 24.5x | 0.05 | CN¥8.32 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.9% Upside | Upgrade to Pro+ | |
Dongxing Securities | Shanghai | Financials | Investment Banking & Investment Services | -6.3% | CN¥33.97B | 21.9x | 0.34 | CN¥10.50 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -19.8% Downside | Upgrade to Pro+ | |
Hangzhou MDK Opto Electronic | Shanghai | Technology | Electronic Equipment & Parts | -6.6% | CN¥3.53B | -39.6x | -2.32 | CN¥8.82 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Holly Futures | Shenzhen | Financials | Investment Banking & Investment Services | -10.5% | CN¥8.08B | 50.8x | 0.34 | CN¥9.61 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Compass | Shenzhen | Technology | Financial Technology (Fintech) & Infrastructure | -12.6% | CN¥37.04B | 158x | 0.28 | CN¥60.37 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -36.8% Downside | Upgrade to Pro+ | |
Guolian Securities Co | Shanghai | Financials | Investment Banking & Investment Services | -15.3% | CN¥54.11B | 11.2x | 0.22 | CN¥9.94 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ |